2019 revenue up 10.3% for theranostics and up 6.4% for IVD Continued improvement in operating income and net income before non-recurring items Positive net income partly driven by non-recurring instrumentation sales. Profits reinvested in development…
Theradiag will hold a conference call to present its 2019 annual results on Thursday, March 19 at 10:00 a.m. To participate, please dial +331.70.71.01.59 followed by the participant PIN code 14 39 06 69 #.…
Croissy-Beaubourg, March 9, 2020, 6:00 pm CET – THERADIAG (ISIN: FR0004197747, Ticker: ALTER), a company specializing in in vitro diagnostics and theranostics, today announces that it has CE marked the first four i-Tracker® test kits…